ESOP-ESO Advanced Masterclass in Oncology Pharmacy
Not eligible for ESCO credits
21.10.2013 - 25.10.2013
Dresden
MASTERCLASS
Description
Chairs: A. Astier, FR - M. Daouphars, FR - P.H. Honoré, SE/DK - E.E. Korczowska, PL - K. Meier, DE - B.J. Sobkowiak, PL - R. Terkola, AT
INTRODUCTION
The European Society of Oncology Pharmacy holds a three level Masterclass programme:
• Basic Masterclass and
• Intermediate Masterclass (held jointly also on 21-25 October in Dresden, Germany)
• Advanced Masterclass
The first two courses are organised by ESOP (further information available at www.esop.eu), whilst herewith the ESOP-ESO Advanced Masterclass is presented.
The Advanced Masterclass will be mainly based on clinical cases covering the majority of diseases and pharmaceutical cases which can occur in the clinical setting. Some cases will be focused on less common cancer entities such as haematological malignancies, paediatric cancer, cancer of geriatric patients, treatment of patients with organ dysfunctions (renal, liver, cardiac, etc.) and rare cancers.
The hematopoietic stem cell transplant patients shall be also covered. Clinical cases should familiarise the oncology pharmacist to complex situations where pharmaceutical expertise is required to improve the treatment (toxicities and their management, symptom management, drug interactions of anticancer agents, management of side-effects, etc.), oncological emergencies and patient counseling. Current practice, recent advances and emerging therapies as well as case studies highlighting pertinent issues shall be introduced. Pharmaceutical situation shall also refer to the content of prior levels like problems concerning drug stability, physico-chemical compatibility and their possible effects on the patient’s therapy.
LEARNING OBJECTIVES
• To actively participate with the medical team to the initial management of a cancer patient whatever the tumor location, i.e. definition of the best chemotherapy and the appropriate support treatment, especially based on pharmacokinetics, pharmacodynamics and pharmacogenetics considerations
• To furnish to medical team and nurses all relevant information about new anticancer treatments, their administration and side-effects with a specific concern on pharmaceutical problems such as stability issues
• To manage the potential side-effects of the treatment by the definition of an appropriate prevention plan and their follow-up, especially for out-patients receiving oral anticancer therapies
• To propose a relevant educational plan for the patient (and its family), related to its treatment, with particular focus on the prevention of drug/drug and drug/food interactions
MAIN TOPICS
• Clinical cases covering the majority of the diseases and pharmaceutical cases that can occur in the clinical setting
• The hematopoietic stem cell transplant patient and other complex situations
• Toxicities and symptom management
• Drug interactions of anticancer agents
• Oncological emergencies
• Patient counseling
• Clinical trials
• Research
• Collective prescription process
• Drug and therapeutic committee
• Pharmaco-economics
General information
ORGANISING SECRETARIAT
ESOP Membership Service
c/o DGOP e.V.
Cuxhavener Straße 36, 21149 Hamburg, Germany
Ph +49 40 790 3356 - Fax: +49 40 791 43601
membershipservice@esop.li
www.esop.eu
Programme
21 October
08:45 | Welcome Coffee |
09:00 | Radiotherapy - Principles and Use in Oncology |
09:45 | Radiotherapy - Principles and Use in Oncology |
10:30 | Treatment of Oncology Patients with Organ Dysfunctions: Renal Impairment H.-P. Lipp |
11:30 | Treatment of Oncology Patients with Organ Dysfunctions: Liver Impairment |
12:30 | Lunch |
13:30 | Clinical Presentation, Diagnosis and Treatment: Lung Cancer E. Laack |
14:30 | Clinical Presentation, Diagnosis and Treatment: Lung Cancer |
15:30 | Coffee Break |
15:45 | Cancer Biology - Etiology of Cancer J. Stanislawiak-Rudowicz |
16:30 | Epidemiology of Cancer & Factors influencing Cancer Development J. Stanislawiak-Rudowicz |
17:15 | Tumor Classification, TNM-System, Grading and Staging M. Dietel |
18:00 | Personalized Oncology and Predictive molecular diagnostic M. Dietel |
22 October
08:30 | Clinical Presentation, Diagnosis and Treatment: Esophageal and Esophagogastric Junction Cancer |
09:15 | Clinical Presentation, Diagnosis and Treatment: Esophageal and Esophagogastric Junction Cancer |
10:00 | Coffee Break |
10:15 | Clinical Presentation, Diagnosis and Treatment: Gastric Cancer |
11:15 | Clinical Presentation, Diagnosis and Treatment: Colon Rectal Cancer |
12:00 | Lunch |
13:00 | G. Wiedemann |
13:45 | P. Mohr |
14:45 | Coffee Break |
15:00 | Clinical Presentation, Diagnosis and Treatment: Non-Melanoma Skin Cancers |
16:00 | Clinical Presentation, Diagnosis and Treatment: Basal and Squamos Cell Skin Cancers P. Mohr |
23 October
08:30 | Clinical Presentation, Diagnosis and Treatment: ALL, AML and CML |
09:30 | Clinical Presentation, Diagnosis and Treatment: ALL, AML and CML |
10:30 | Coffee Break |
10:45 | Clinical Presentation, Diagnosis and Treatment: Hodgkin and Non-Hodgkin Lymphoma |
11:45 | Clinical Presentation, Diagnosis and Treatment: Breast Cancer |
12:45 | Lunch |
13:45 | Clinical Presentation, Diagnosis and Treatment: Breast Cancer K. Possinger |
14:45 | Clinical Presentation, Diagnosis and Treatment: Head and Neck Cancer S. Koscielny |
15:30 | Clinical Presentation, Diagnosis and Treatment: Head and Neck Cancer |
16:15 | Coffee Break |
16:30 | Clinical Presentation, Diagnosis and Treatment: Soft Tissue Sarcoma P. Reichardt |
17:30 | Clinical Presentation, Diagnosis and Treatment: Soft Tissue Sarcoma P. Reichardt |
24 October
08:30 | Side Effects of Anticancer Drugs |
09:30 | Side Effects of Anticancer Drugs |
10:30 | Interactions of Anticancer Drugs |
11:30 | Lunch |
12:30 | Clinical Presentation, Diagnosis and Treatment: Ovarian Cancer |
13:30 | Clinical Presentation, Diagnosis and Treatment: Cervical Cancer |
14:30 | Coffee Break |
14:45 | Clinical Presentation, Diagnosis and Treatment: Prostate and Bladder Cancer |
15:45 | Clinical Presentation, Diagnosis and Treatment: Penile, Testicular and Kidney Cancer |
16:45 | Coffee Break |
17:00 | Treatment of Pediatric Oncology Patients P. Hartvig-Honoré |
17:45 | Treatment of Geriatric Oncology Patients P. Hartvig-Honoré |
25 March
08:30 | Multiprofessional Cases |
09:30 | M. Höckel |
10:30 | Coffee Break |
10:45 | M. Höckel |
11:45 | M. Höckel |
12:45 | Lunch |
13:45 | M. Höckel |
14:30 | M. Höckel Multiprofessional Cases |
15:30 | Coffee Break |
15:45 | Interactive session: Test and Masterclass Evaluation Questionaire & Farewell |